return to small text site

 

for patients

press releases

press coverage
electronic press kit
Luveniq

LX214

LX212
proprietary technologies
pipeline

uveitis

dry eye syndrome

age-related macular degeneration

history
management
board of directors

investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  MANAGEMENT PHOTOS
 

Dean J. Mitchell
President & Chief Executive Officer

A. Clarke Atwell
Founder, Chief Operating Officer

Eddy Anglade, M.D.
Founder, Chief Medical Officer

 

© 2009 Lux Biosciences, Inc. All rights reserved.           Web Terms           Clinical Trials